Written Question·Department of Health and Social Care·UIN 118682

Glioblastoma: Medical Treatments

Tabled: 9 March 2026
Answered: 18 March 2026

Question

Sir Iain Duncan Smith

ConservativeChingford and Woodford Green

To ask the Secretary of State for Health and Social Care, what new personalised treatments for glioblastoma are being assessed.

Answer

Dr Zubir Ahmed
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for assessing new medicines to ensure they meet the required standards of quality, safety, and efficacy before they can be authorised for use in the United Kingdom. The MHRA con...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 118682) →